Correlation Between Kiora Pharmaceuticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Kiora Pharmaceuticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiora Pharmaceuticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiora Pharmaceuticals and Virax Biolabs Group, you can compare the effects of market volatilities on Kiora Pharmaceuticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiora Pharmaceuticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiora Pharmaceuticals and Virax Biolabs.
Diversification Opportunities for Kiora Pharmaceuticals and Virax Biolabs
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kiora and Virax is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Kiora Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiora Pharmaceuticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Kiora Pharmaceuticals i.e., Kiora Pharmaceuticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Kiora Pharmaceuticals and Virax Biolabs
Given the investment horizon of 90 days Kiora Pharmaceuticals is expected to generate 34.71 times less return on investment than Virax Biolabs. But when comparing it to its historical volatility, Kiora Pharmaceuticals is 2.36 times less risky than Virax Biolabs. It trades about 0.0 of its potential returns per unit of risk. Virax Biolabs Group is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 210.00 in Virax Biolabs Group on August 27, 2024 and sell it today you would lose (9.00) from holding Virax Biolabs Group or give up 4.29% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Kiora Pharmaceuticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Kiora Pharmaceuticals |
| Virax Biolabs Group |
Kiora Pharmaceuticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiora Pharmaceuticals and Virax Biolabs
The main advantage of trading using opposite Kiora Pharmaceuticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiora Pharmaceuticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
| Virax Biolabs vs. Eliem Therapeutics | Virax Biolabs vs. HCW Biologics | Virax Biolabs vs. Scpharmaceuticals | Virax Biolabs vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |